<DOC>
	<DOCNO>NCT00413322</DOCNO>
	<brief_summary>This study assess combination PXD101 5-Fluorouracil ( 5-FU ) patient advance solid tumor . The primary goal study understand safety , anti-tumor activity , study drug behaves within body give 5-Fluorouracil ( 5-FU ) .</brief_summary>
	<brief_title>Study PXD101 Alone Combination With 5-Fluorouracil ( 5-FU ) Patients With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Belinostat</mesh_term>
	<criteria>Histologically confirm solid tumor Advanced colorectal cancer adenocarcinomas Tumor progression standard chemotherapy , none yet approve At least one unidimensionally measurable lesion Karnofsky performance &gt; = 70 % Life expectancy least 3 month Age &gt; = 18 year Signed , write Institutional Review Board ( IRB ) approve informed consent Acceptable liver function : Bilirubin &lt; = 1.5 x upper limit normal ( ULN ) AST ( SGOT ) ALT ( SGPT ) &lt; = 2.5 x ULN , OR AST ( SGOT ) ALT ( SGPT ) &lt; = 5 x ULN liver metastasis Acceptable renal function : Serum creatinine within normal limit , OR Calculated creatinine clearance &gt; = 60 mL/min/1.73 m2 certain patient Acceptable hematologic status : Absolute neutrophil count ( ANC ) &gt; = 1500 cells/mm3 Platelet count &gt; = 100,000 ( plt/mm3 ) Hemoglobin &gt; = 9 g/dL Urinalysis : No clinically significant abnormality Acceptable coagulation status : Prothrombin time ( PT ) /partial thromboplastin time ( PTT ) within normal limit , OR For patient anticoagulation therapy , status within therapeutic range For men woman childproducing potential , use effective contraception Tumors accessible needle biopsy Significant cardiovascular disease . A marked baseline prolongation QT/QTc interval Long QT syndrome Required use medication dose day may cause torsade de pointes . Infections require intravenous ( IV ) systemic therapy Pregnant nursing woman Treatment chemotherapy investigational therapy &lt; 4 week ( 28 day ) prior study entry ( 6 week nitrosoureas , mitomycin C , Avastin ) . Treatment radiation therapy surgery either within 2 week prior study entry , yet recover 24 week prior study entry . Unwillingness inability comply protocol procedure . Known active uncontrolled infection HIV , hepatitis B , hepatitis C Serious nonmalignant disease ( e.g . hydronephrosis , liver failure , condition ) could compromise protocol objective opinion investigator and/or sponsor Concurrent use investigational agent ( ) Serious concurrent medical illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Advanced Solid tumor</keyword>
	<keyword>Adenosarcoma</keyword>
	<keyword>Androgen-independent prostate cancer</keyword>
	<keyword>belinostat</keyword>
	<keyword>bladder cancer</keyword>
	<keyword>bladder neoplasm</keyword>
	<keyword>Breast cancer</keyword>
	<keyword>Carcinoma , Bronchogenic</keyword>
	<keyword>Carcinoma , Non-Small-Cell Lung</keyword>
	<keyword>Carcinoma , Small Cell</keyword>
	<keyword>Carcinosarcoma</keyword>
	<keyword>Chondrosarcoma</keyword>
	<keyword>Coin Lesion , Pulmonary</keyword>
	<keyword>colorectal cancer</keyword>
	<keyword>Esophageal Neoplasms</keyword>
	<keyword>Facial Neoplasms</keyword>
	<keyword>Fibrosarcoma</keyword>
	<keyword>head neck cancer</keyword>
	<keyword>Hemangiosarcoma</keyword>
	<keyword>Histiocytoma , Malignant Fibrous</keyword>
	<keyword>kidney cancer</keyword>
	<keyword>Leiomyosarcoma</keyword>
	<keyword>Liposarcoma</keyword>
	<keyword>lung cancer</keyword>
	<keyword>lung neoplasm</keyword>
	<keyword>Lymphangiosarcoma</keyword>
	<keyword>mesothelioma</keyword>
	<keyword>mesothelioma , cystic</keyword>
	<keyword>Mixed Tumor , Mesodermal</keyword>
	<keyword>Mouth Neoplasms</keyword>
	<keyword>Myosarcoma</keyword>
	<keyword>Myxosarcoma</keyword>
	<keyword>Osteosarcoma</keyword>
	<keyword>Otorhinolaryngologic Neoplasms</keyword>
	<keyword>Ovarian cancer</keyword>
	<keyword>Pancoast 's Syndrome</keyword>
	<keyword>Parathyroid Neoplasms</keyword>
	<keyword>Phyllodes Tumor</keyword>
	<keyword>Pulmonary Sclerosing Hemangioma</keyword>
	<keyword>sarcoma</keyword>
	<keyword>thyroid cancer</keyword>
	<keyword>Thyroid Neoplasms</keyword>
	<keyword>Tracheal Neoplasms</keyword>
	<keyword>PXD101</keyword>
</DOC>